⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NTLA News
Intellia Therapeutics, Inc
U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs
globenewswire.com
BMY
GILD
JNJ
SNY
TAK
AMGN
AZN
LLY
MRK
PFE
REGN
VRTX
ABBV
ALNY
AMTX
BIIB
BMRN
CRSP
EXAS
INCY
IONS
JAZZ
NTLA
PTC
RGEN
XOM
Biohacking Market to Reach US$ 216.68 Billion by 2035 Driven by Metabolic Monitoring, Wearable Diagnostics, and Personalized Health Optimization | Astute Analytica
globenewswire.com
GOOG
ABT
DXCM
NVDA
CRSP
NTLA
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NTLA
Cell and Gene Therapy in Numbers: $1.2B in Zolgensma Sales, $1.5B Yescarta Revenue, 46 FDA-Approved Therapies and $2B Strategic Deals
globenewswire.com
NVS
GILD
BMY
REGN
CRSP
NTLA
EDIT
BBIO
AZN
SGMO
Leading Chinese Innovative Medical Device Maker Insight Lifetech Has Successfully Listed on STAR Market USA - English APAC - Traditional Chinese USA - English
prnewswire.com
AAPL
TSLA
XOM
MSFT
GOOGL
AMZN
NVDA
META
BRK.A
JPM
V
JNJ
PG
MA
HD
UNH
DIS
BAC
PFE
MRK
TMO
ABT
MDT
BMY
AMGN
GILD
AZN
LLY
BIIB
REGN
VRTX
ALGN
ISRG
TDOC
EXAS
ZLAB
SCHR
APT
BILI
HSAI
UBOT
TIGR
INSM
YXT
CCEL
IMUX
INCY
CRSP
EDIT
NTLA
SRPT
EXEL
LULU
CROX
NKE
CPRI
PVH
RL
URBN
M
KSS
TJX
BBY
ROST
DLTR
WMT
TGT
COST
SBUX
MCD
CMG
YUM
QSR
CBRL
TXRH
NDSN
TTWO
EA
NTDOY
SONY
MSGS
AMC
IMAX
RCL
CCL
NCLH
AAL
DAL
UAL
LUV
ALK
JBLU
SKX
ADBE
CRM
INTC
AMD
QCOM
AMAT
MU
NXPI
SNPS
CDNS
ASML
PAYX
ADP
NOW
CSCO
ORCL
IBM
HPQ
DELL
ACN
INFY
SAP
ERIC
NOK
STM
UL
PEP
KO
Quantum Secure Communication Market to Reach US$ 1,861.78 Million by 2035 Driven by Capital Inflows, Government Initiatives, and Telecom Network Adoption Says Astute Analytica
globenewswire.com
GOOG
JPM
VZ
T
TM
NTES
CHTR
ARQQ
KT
SKM
TSLA
MSFT
AMZN
NVDA
IBM
QCOM
INTC
CSCO
ORCL
CRM
ACN
ADP
FIS
PYPL
COIN
MU
ADI
NXPI
ON
QTRX
AEHR
MCHP
SWKS
QRVO
AVGO
MRVL
AMD
IONQ
RIG
CRIS
EDIT
NTLA
ALNY
BIIB
GILD
REGN
AMGN
BMY
PFE
MRK
ABBV
LLY
SNY
AZN
NVS
XOM
CVX
SHEL
BABA
JD
PDD
BIDU
IQ
VIPS
NIO
LI
XPEV
RIVN
LCID
F
GM
STLA
HMC
SONY
HPQ
DELL
HPE
Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine
globenewswire.com
NTLA
EDIT
CRSP
Cell and Gene Therapy Market Poised for US$ 183.1 Billion Growth by 2035 | Astute Analytica
globenewswire.com
NTLA
EDIT
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN
globenewswire.com
NTLA
Gene Therapy Investment Trends Strategic Intelligence Report 2026: Market to Reach $42.26 Billion by 2033 | Astute Analytica
globenewswire.com
EDIT
NTLA
PFE